Our vision is to revolutionize the treatment of vision disorders through non-surgical, globally disruptive therapies. We are dedicated to developing a novel corneal remodeling therapy for patients with ectatic disorders like keratoconus, offering a safer and more effective alternative to traditional...See more
Headquarter New Zealand |
Funding status Private |
Company type SME |
Research and Operations Manager
VCFO
Chief Executive Officer